Merck withdraws from UK research, cancels London £1bn facility
TL;DR Summary
Merck is halting its research operations in the UK and abandoning a new London research center due to frustrations with the UK's medicine pricing and support policies, highlighting concerns from the pharma industry about the country's attractiveness for research investment.
- Merck halts U.K. research operations and bails on new facility in London statnews.com
- US drugmaker Merck scraps £1bn London research centre and cuts 125 science jobs The Guardian
- Merck slams UK as it scraps £1bn London drug research centre Financial Times
- Merck executes its own Brexit, moving all R&D operations out of UK Fierce Biotech
- Merck scraps plans for $1.3B London lab as pharma continues to divest from the UK Endpoints News
Reading Insights
Total Reads
0
Unique Readers
19
Time Saved
1 min
vs 2 min read
Condensed
81%
211 → 40 words
Want the full story? Read the original article
Read on statnews.com